Cargando…
Altered expression of the immunoregulatory ligand-receptor pair CD200-CD200R1 in the brain of Parkinson’s disease patients
Neuroinflammation, in which activated microglia are involved, appears to contribute to the development of Parkinson’s disease (PD). However, the role of microglial activation and the mechanisms governing this process remain uncertain. We focused on one inhibitory mechanism involved in the control of...
Autores principales: | Rabaneda-Lombarte, Neus, Vidal-Taboada, José Manuel, Valente, Tony, Ezquerra, Mario, Fernández-Santiago, Rubén, Martí, María José, Compta, Yaroslau, Saura, Josep, Solà, Carme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927151/ https://www.ncbi.nlm.nih.gov/pubmed/35296683 http://dx.doi.org/10.1038/s41531-022-00290-2 |
Ejemplares similares
-
Parkinsonian neurotoxicants impair the anti-inflammatory response induced by IL4 in glial cells: involvement of the CD200-CD200R1 ligand-receptor pair
por: Rabaneda-Lombarte, Neus, et al.
Publicado: (2020) -
The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson’s disease
por: Rabaneda-Lombarte, Neus, et al.
Publicado: (2021) -
Alterations in CD200-CD200R1 System during EAE Already Manifest at Presymptomatic Stages
por: Valente, Tony, et al.
Publicado: (2017) -
Parkinsonian Neurotoxins Impair the Pro-inflammatory Response of Glial Cells
por: Rabaneda-Lombarte, Neus, et al.
Publicado: (2019) -
Inhibition of CD200R1 expression by C/EBP beta in reactive microglial cells
por: Dentesano, Guido, et al.
Publicado: (2012)